APA (7th ed.) Citation

LY, Y., PW, S., YH, W., YW, Y., KW, C., CR, L., . . . CL, L. (2026). Multiprotein-based nanomedicines with dual CD44/CD133 targeting and GSH-responsive drug release for improving cancer chemotherapy. Drug delivery and translational research. https://doi.org/10.1007/s13346-026-02145-2

Chicago Style (17th ed.) Citation

LY, Yu, Shueng PW, Wang YH, Yen YW, Chen KW, Li CR, Chiu HC, Lin YW, and Lo CL. "Multiprotein-based Nanomedicines with Dual CD44/CD133 Targeting and GSH-responsive Drug Release for Improving Cancer Chemotherapy." Drug Delivery and Translational Research 2026. https://doi.org/10.1007/s13346-026-02145-2.

MLA (9th ed.) Citation

LY, Yu, et al. "Multiprotein-based Nanomedicines with Dual CD44/CD133 Targeting and GSH-responsive Drug Release for Improving Cancer Chemotherapy." Drug Delivery and Translational Research, 2026, https://doi.org/10.1007/s13346-026-02145-2.